Multi-diagnostic approaches for patient selection biomarkers in immuno-oncology
28:23
Description
Related Videos
View More
View Less
Related Videos
In Laboratory Webinars
-
Play video Laboratory Considerations When Developing Multiple Myeloma Trials
Laboratory Considerations When Developing Multiple Myeloma Trials
Join ICON’s experts Dr. Marc Golightly, PhD and Domenica Gandini as they speak about considerations when developing Multiple Myeloma trials. With the growing number of therapeutics being developed for Multiple Myeloma, the need for laboratory expert
58:49
-
Play video Biomarker assays - bioanalytical meets CLIA
Biomarker assays - bioanalytical meets CLIA
46:53
-
Play video NASH Clinical Trials: Challenges and Considerations
NASH Clinical Trials: Challenges and Considerations
Dr. Andrew Roche discusses overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.
46:50
-
Play video Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500
Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500
57:36
-
Play video Best practices for the validation of hybrid LC-MS/MS assays
Best practices for the validation of hybrid LC-MS/MS assays
55:01
-
Play video Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials
Best practices for laboratory solutions relating to Cell and Gene Therapy clinical trials
1:01:13